|
Market Closed -
Nasdaq
16:00:00 2026-09-15 EDT
|
5-day change | 1st Jan Change | ||
| 17.40 USD | -5.54% |
|
+0.69% | -0.51% |
| 09-09 | Summit Therapeutics Shares Rise After Upgrade From Jefferies | MT |
| 09-09 | Jefferies Upgrades Summit Therapeutics to Buy From Hold, Adjusts Price Target to $25 From $15 | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 21.55 | +57.67% | 13 | ||||||
| 187.07 | +17.76% | 18 | ||||||
| 1,179.34 | +17.76% | 15 | ||||||
| 200.18 | +59.76% | 22 | ||||||
| 49.74 | +18.28% | 24 | ||||||
| 102.51 | +19.67% | 20 | ||||||
| 2,453.79 | +15.96% | 15 | ||||||
| 1,397.26 | +17.42% | 8 | ||||||
| 619.67 | +28.78% | 19 | ||||||
| 53.69 | -4.49% | 16 | ||||||
| 678.06 | +25.55% | 16 | ||||||
| 110 | +36.36% | 12 | ||||||
| 134.62 | +64.35% | 21 | ||||||
| 109.9 | +51.69% | 20 | ||||||
| 109 | +83.07% | 9 | ||||||
| 12.75 | +52.33% | 4 | ||||||
| 100.18 | +53.84% | 16 | ||||||
| 120.08 | +32.24% | 13 | ||||||
| 228.89 | +32.31% | 9 | ||||||
| Average | 414.12 | +35.81% | 15 | ||||||
| Weighted average by Cap. | 513.9 | +28.90% | 17 |
- Stock Market
- Stocks
- SMMT Stock
- Sector Summit Therapeutics Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
